Clinical trial
Phase 2 Study of HKI-272 In Subjects With Advanced Breast Cancer
NCT00300781 is registered in ClinicalTrials.gov with Puma Biotechnology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of HKI-272 In Subjects With Advanced Breast Cancer
- Lead sponsor
- Puma Biotechnology, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 4, 2006
- Completion date
- January 30, 2018
- Enrollment
- 136 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.